GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oxford Nanopore Technologies PLC (LSE:ONT) » Definitions » Total Liabilities

Oxford Nanopore Technologies (LSE:ONT) Total Liabilities : £133.2 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Oxford Nanopore Technologies Total Liabilities?

Oxford Nanopore Technologies's Total Liabilities for the quarter that ended in Dec. 2023 was £133.2 Mil.

Oxford Nanopore Technologies's quarterly Total Liabilities declined from Dec. 2022 (£130.33 Mil) to Jun. 2023 (£117.61 Mil) but then increased from Jun. 2023 (£117.61 Mil) to Dec. 2023 (£133.21 Mil).

Oxford Nanopore Technologies's annual Total Liabilities declined from Dec. 2021 (£137.89 Mil) to Dec. 2022 (£130.33 Mil) but then increased from Dec. 2022 (£130.33 Mil) to Dec. 2023 (£133.21 Mil).


Oxford Nanopore Technologies Total Liabilities Historical Data

The historical data trend for Oxford Nanopore Technologies's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oxford Nanopore Technologies Total Liabilities Chart

Oxford Nanopore Technologies Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 55.21 95.28 137.89 130.33 133.21

Oxford Nanopore Technologies Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 137.89 116.21 130.33 117.61 133.21

Oxford Nanopore Technologies Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Oxford Nanopore Technologies's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=89.199+(37.333+6.679
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=133.2

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=777.062-643.851
=133.2

Oxford Nanopore Technologies's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=89.199+(37.333+6.679
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=133.2

Total Liabilities=Total Assets (Q: Dec. 2023 )-Total Equity (Q: Dec. 2023 )
=777.062-643.851
=133.2

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Oxford Nanopore Technologies Total Liabilities Related Terms

Thank you for viewing the detailed overview of Oxford Nanopore Technologies's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Oxford Nanopore Technologies (LSE:ONT) Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Gosling Building, Oxford Science Park, Oxford, Oxfordshire, GBR, OX44DQ
Oxford Nanopore Technologies PLC makes a novel generation of DNA/RNA sequencing technology that provides rich data and is fast, accessible, and easy to use. The Group is primarily involved in researching, developing, manufacturing, and commercializing the world's only commercial nanopore-based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA). This enables our customers to perform scientific/biomedical research in a range of areas, including human genetics, cancer research, outbreak surveillance, environmental analysis, pathogens/antimicrobial resistance, microbiome analysis, and crop science.

Oxford Nanopore Technologies (LSE:ONT) Headlines

No Headlines